Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health services and systems news

Show

From To
HIV drugmakers ViiV, Gilead top 2018 pharma reputation survey

Viiv, Gilead and Janssen led among global pharma companies in PatientView's annual reputation survey of patient groups.

Published
23 April 2019
From
FiercePharma
Seattle HIV cluster found in drug users, those without homes

The opioid epidemic and a rising population of people experiencing homelessness have helped fuel an HIV outbreak in North Seattle.

Published
23 April 2019
From
San Francisco Chronicle
Drag troupe 'The Sisters of Perpetual Indulgence' mark 40 years of 'dragtivism'

Four decades since they began in San Francisco, The Sisters of Perpetual Indulgence and their campy activism have inspired others, according to member Sister Roma.

Published
23 April 2019
From
NBC News
Trump has Vowed to End the HIV/AIDS Epidemic. His Court Picks Have Other Ideas.

Health and Human Services Secretary Alex Azar is currently on a media swing touting the Trump Administration’s pledge to end the HIV/AIDS epidemic by 2030. But given the administration’s actions to create a federal judiciary wholly inhospitable to both accessible health care and the LGBTQ community, this is breathtaking hypocrisy—and Azar should know it.

Published
23 April 2019
From
Daily Beast
HIV infection rates in New South Wales hit record low, but there are concerns

The number of new HIV cases in NSW has dropped to their lowest level since 1984, but NSW Health would not say whether it will hit its target of "virtually" eliminating the disease by 2020.

Published
23 April 2019
From
Sydney Morning Herald
A Promising Anti-HIV Drug Poses A Dilemma

The anti-HIV drug dolutegravir is effective — but may carry a risk for pregnant women. While women in wealthy countries are given choices about their medical care, for women in poor countries the situation is different. There aren't enough doctors and nurses to explain the risks and benefits of the new drug to every patient. The country may not have the resources to keep supplies of two different drugs on the shelves. And there is no consistent access to effective birth control.

Published
23 April 2019
From
NPR
Thousands feared at risk after Mexico reforms HIV+ regime

Thousands of Mexicans living with HIV or at risk of infection could be left without life-saving services after the government changed the way it funds treatment, according to public health experts and LGBT+ rights advocates.

Published
18 April 2019
From
Reuters
Gilead's first big TV push for triple combo Biktarvy showcases HIV diversity

Gilead Sciences wanted to represent the wide range of people living with HIV in its first national TV campaign for Biktarvy. So they chose black, Latino, male, female, gay, bisexual and transgender actors for an ad that encourages people with HIV to “keep being you.”

Published
18 April 2019
From
FiercePharma
Letter to FDA Regarding Application for Descovy as Pre-Exposure Prophylaxis for HIV

TAG and PrEP4All sent this letter to Dr. Debra Birnkrant of the FDA, outlining and expressing our serious concerns about Gilead’s supplemental New Drug Application for Descovy (FTC/TAF) as HIV-1 preexposure prophylaxis (PrEP). There are several specific recommendations in the letter for this approval process, including recomending that the FDA convene a public meeting of the Antiviral Drug Advisory Committee.

Published
17 April 2019
From
Treatment Action Group
Long-Acting HIV Treatment Is Coming. Our Health Care System Needs to Prepare

New conversations are starting in HIV care as phase III trials have shown that monthly injections of cabotegravir and rilpivirine (Edurant) are non-inferior to a three-drug pill regimen. In 2018, TheBody asked a range of people living with HIV about their willingness to switch to an injectible, and most had mixed feelings. But even if there's widespread interest in this new way of taking antiretroviral therapy (and most likely also prevention, not too far away), it's important to consider not just the willingness of people to move to this new form of treatment, but whether health care systems and providers in the U.S. are ready to support this innovation.

Published
16 April 2019
From
The Body Pro
← First12345...550Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.